<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:com="http://www.sec.gov/edgar/common">
  <schemaVersion>X0202</schemaVersion>
<headerData>
    <submissionType>SCHEDULE 13G/A</submissionType>
		<previousAccessionNumber>0001687078-26-000005</previousAccessionNumber>
	    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001687078</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>





    </filerInfo>
  </headerData>

  <formData>
    <coverPageHeader>
		<amendmentNo>2</amendmentNo>
	      <securitiesClassTitle>Common Stock, par value $0.001 per share</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>06/30/2026</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0001842952</issuerCik>        <issuerName>Context Therapeutics Inc.</issuerName>

    <issuerCusips>
					<issuerCusipNumber>21077P108</issuerCusipNumber>
				</issuerCusips>

        <issuerPrincipalExecutiveOfficeAddress>
          <com:street1>2001 MARKET STREET</com:street1>
          <com:street2>SUITE 3915 UNIT #15</com:street2>          <com:city>PHILADELPHIA</com:city>
          <com:stateOrCountry>PA</com:stateOrCountry>
          <com:zipCode>19103</com:zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>

	        <designateRulesPursuantThisScheduleFiled>
	   		        <designateRulePursuantThisScheduleFiled>Rule 13d-1(b)</designateRulePursuantThisScheduleFiled>
				      </designateRulesPursuantThisScheduleFiled>

    </coverPageHeader>

	    <coverPageHeaderReportingPersonDetails>




    <reportingPersonName>MPM BioImpact LLC </reportingPersonName>



		 <citizenshipOrOrganization>DE</citizenshipOrOrganization>

      <reportingPersonBeneficiallyOwnedNumberOfShares>
                <soleVotingPower>1299046.00</soleVotingPower>
                          <sharedVotingPower>0.00</sharedVotingPower>
                          <soleDispositivePower>1299046.00</soleDispositivePower>
                         <sharedDispositivePower>0.00</sharedDispositivePower>
             </reportingPersonBeneficiallyOwnedNumberOfShares>

              <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>1299046.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>


     	    <classPercent>1.4</classPercent>




	  	  	  	  <typeOfReportingPerson>IA</typeOfReportingPerson>










    </coverPageHeaderReportingPersonDetails>

    <items>
      <item1>
        <issuerName>Context Therapeutics Inc.</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>2001 MARKET STREET, SUITE 3915 UNIT #15, PHILADELPHIA, PA, 19103.</issuerPrincipalExecutiveOfficeAddress>
      </item1>

      <item2>
        <filingPersonName>MPM BioImpact LLC</filingPersonName>        <principalBusinessOfficeOrResidenceAddress>399 Boylston Street, Suite 1100
Boston, MA 02116</principalBusinessOfficeOrResidenceAddress>        <citizenship>Delaware</citizenship>      </item2>

        <item3>
				<notApplicableFlag>N</notApplicableFlag>





		<typeOfPersonFiling>IA</typeOfPersonFiling>









      </item3>



    <item4>
    <amountBeneficiallyOwned>1,299,046</amountBeneficiallyOwned>    <classPercent>1.4%</classPercent>
      <numberOfSharesPersonHas>
        <solePowerOrDirectToVote>1,299,046</solePowerOrDirectToVote>
        <sharedPowerOrDirectToVote>0</sharedPowerOrDirectToVote>
        <solePowerOrDirectToDispose>1,299,046</solePowerOrDirectToDispose>
        <sharedPowerOrDirectToDispose>0</sharedPowerOrDirectToDispose>
      </numberOfSharesPersonHas>
    </item4>


        <item5>

            <notApplicableFlag>N</notApplicableFlag>
        <classOwnership5PercentOrLess>Y</classOwnership5PercentOrLess>

    </item5>


        <item6>
	  	  <notApplicableFlag>Y</notApplicableFlag>
		        </item6>


        <item7>
	  	  <notApplicableFlag>Y</notApplicableFlag>


    </item7>


          <item8>
                <notApplicableFlag>Y</notApplicableFlag>

              </item8>


            <item9>
                <notApplicableFlag>Y</notApplicableFlag>
                      </item9>


      <item10>
                <notApplicableFlag>N</notApplicableFlag>
        <certifications>By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.</certifications>

      </item10>
    </items>


	    <signatureInformation>
      <reportingPersonName>MPM BioImpact LLC </reportingPersonName>

      <signatureDetails>
        <signature>Christopher Wolf</signature>
        <title>Chief Financial Officer</title>
        <date>08/14/2026</date>
      </signatureDetails>

    </signatureInformation>



  </formData>

    </edgarSubmission>
